English
Home > Products > 2-[1-(Mercaptomethyl)cyclopropyl]acetic

China 2-[1-(Mercaptomethyl)cyclopropyl]acetic Factory

We believe that extensive time period partnership can be a result of top quality, price added support, loaded encounter and personal contact for 2-[1-(Mercaptomethyl)cyclopropyl]acetic,CAS NO 162515-68-6,162515-68-6,Montelukast Sodium intermediate,Montelukast Sodium advance intermediate, Accurate process devices, Advanced Injection Molding Equipment, Equipment assembly line, labs and software advancement are our distinguishing feature.
2-[1-(Mercaptomethyl)cyclopropyl]acetic, We adopted technique and quality system management, based on "customer orientated, reputation first, mutual benefit, develop with joint efforts", welcome friends to communicate and cooperate from all over the world.

Related Products

Hot Products

  • Varenicline tartrate

    Varenicline tartrate

    Product Name:Varenicline tartrate
    Molecular Formula:C17H19N3O6
    Molecular Weight:361.35
    CAS Registry Number:375815-87-5
  • Phenylbutazone

    Phenylbutazone

    Product Name:Phenylbutazone
    Molecular Formula:C19H20N2O2
    Molecular Weight;308.37
    CAS Registry Number;50-33-9
  • 1-tert-Butoxycarbonyl-4-piperidinecarboxaldehyde

    1-tert-Butoxycarbonyl-4-piperidinecarboxaldehyde

    Product Name:1-tert-Butoxycarbonyl-4-piperidinecarboxaldehyde
    Molecular Formula:C11H19NO3
    Molecular Weight:213.27
    CAS Registry Number:137076-22-3
  • 2,3-Difluorobenzonitrile

    2,3-Difluorobenzonitrile

    Product Name:2,3-Difluorobenzonitrile
    Molecular Formula:C7H3F2N
    Molecular Weight:139.1
    CAS Registry Number:21524-39-0
  • Rifampicin Capsules

    Rifampicin Capsules

    Product Name:Rifampicin Capsules
    Dosage:0.15g
    Application:Antibiotic
  • 1-(2,3-Dimethylphenyl)ethyl chloride

    1-(2,3-Dimethylphenyl)ethyl chloride

    Product Name:1-(2,3-Dimethylphenyl)ethyl chloride
    Molecular Formula:C10H13Cl
    Molecular Weight:168.66
    CAS Registry Number:60907-88-2
  • Related Blog
  • Reviews

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • TOP 8 Linezolid intermediate maker

    Sandoo Pharmaceuticals and Chemicals Co.,Ltd was established in 2009, with a creative and active team, located in Ningbo, China. We have been specialized in exporting and importing pharmaceutical intermediates and chemical products as well as API for more than 10 years, covering more than 10 countries.

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept